Tower Research Capital (TRC)’s Adial Pharmaceuticals ADIL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $429 | Sell |
1,419
-8
| -0.6% | -$2 | ﹤0.01% | 5027 |
|
|
2025
Q1 | $905 | Buy |
1,427
+789
| +124% | +$500 | ﹤0.01% | 4806 |
|
|
2024
Q4 | $644 | Sell |
638
-3,305
| -84% | -$3.34K | ﹤0.01% | 5214 |
|
|
2024
Q3 | $3.94K | Sell |
3,943
-1,689
| -30% | -$1.69K | ﹤0.01% | 4732 |
|
|
2024
Q2 | $6.48K | Buy |
5,632
+1,007
| +22% | +$1.16K | ﹤0.01% | 4575 |
|
|
2024
Q1 | $6.15K | Buy |
4,625
+391
| +9% | +$520 | ﹤0.01% | 4425 |
|
|
2023
Q4 | $7.88K | Buy |
+4,234
| New | +$7.88K | ﹤0.01% | 4569 |
|
|
2022
Q3 | – | Sell |
-264
| Closed | -$9K | – | 6016 |
|
|
2022
Q2 | $9K | Buy |
264
+52
| +25% | +$1.77K | ﹤0.01% | 4533 |
|
|
2022
Q1 | $11K | Buy |
+212
| New | +$11K | ﹤0.01% | 4137 |
|
|
2021
Q4 | – | Sell |
-4
| Closed | – | – | 6094 |
|
|
2021
Q3 | $0 | Sell |
4
-15
| -79% | – | ﹤0.01% | 5722 |
|
|
2021
Q2 | $1K | Sell |
19
-36
| -65% | -$1.9K | ﹤0.01% | 5162 |
|
|
2021
Q1 | $3K | Sell |
55
-26
| -32% | -$1.42K | ﹤0.01% | 4874 |
|
|
2020
Q4 | $3K | Sell |
81
-7
| -8% | -$259 | ﹤0.01% | 4774 |
|
|
2020
Q3 | $5K | Buy |
+88
| New | +$5K | ﹤0.01% | 4336 |
|
|
2018
Q4 | – | Sell |
-26
| Closed | -$2K | – | 3779 |
|
|
2018
Q3 | $2K | Buy |
+26
| New | +$2K | ﹤0.01% | 3395 |
|